HCA Healthcare, Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Healthcare Added 35,200 Jobsβ€”3 Stocks Positioned to Benefit - MarketBeat

AI-generated analysis

πŸ“ˆ Healthcare added 35,200 jobs in May, led by 25,700 in ambulatory services and 6,000 in hospitals, signaling sustained demand.

πŸ’Ό UnitedHealth Group (UNH) reported Q1 2026 revenue of $111.7 billion and raised full-year EPS guidance to above $18.25.

πŸ₯ HCA Healthcare (HCA) achieved a 4.3% revenue increase to $19.1 billion in Q1 2026 with operating cash flow up 22%.

πŸ”„ Encompass Health (EHC) saw adjusted EPS surge 16.8% and raised full-year revenue guidance to $6.375-$6.47 billion.

πŸ“‰ UNH medical benefit ratio improved to 83.9%, reflecting better cost management and normalized pressure.

πŸ—οΈ HCA deployed $1.1 billion in capital expenditures while repurchasing $1.6 billion in shares during Q1 2026.

πŸš€ EHC is expanding with seven new hospitals opening in 2026 and adding 100-150 beds to existing facilities.

πŸ‘₯ EHC nurse turnover hit its lowest level since 2012, providing a tangible labor cost benefit.

πŸ’° Analysts give HCA a consensus price target of $506.14, implying a potential 30% gain from current levels.

🎯 Encompass Health has a consensus Buy rating with a $143.86 price target suggesting over 40% upside.

Bullish Signals
  • Healthcare employment growth is consistent and structural, averaging roughly 38,000 new jobs per month over the past year.
  • UnitedHealth Group's medical benefit ratio improved to 83.9%, indicating better cost management and normalization of sector pressures.
  • HCA Healthcare operating cash flow strengthened significantly to $2 billion, a 22% jump from the prior-year quarter.
  • Encompass Health reported its best earnings in recent history with revenue up 9% and adjusted EPS up 16.8%.
  • Encompass Health's discharge-to-community rate improved by 50 basis points to 84.5%, enhancing operational efficiency.
  • HCA Healthcare is actively investing in capacity with $1.1 billion in Q1 capital expenditures to meet rising demand.
  • Encompass Health is expanding its footprint with seven new hospitals scheduled to open in 2026.
  • Analysts maintain a consensus Buy rating for Encompass Health with a price target implying over 40% upside potential.
Risk Factors
  • UnitedHealth Group is trading at a slight premium of 22x forward earnings compared to its historic average.
  • HCA Healthcare stock is down over 16% in 2026 and remains well below its all-time high from February.
  • Encompass Health stock is down about 4% in 2026 despite strong operational performance.
Full Analysis
The U.S. healthcare sector added 35,200 jobs in May, extending a year-long trend of robust employment growth driven by sustained demand for medical services. This expansion is led by ambulatory health services, which added 25,700 positions, and hospitals, which added 6,000. Analysts view this consistency as a signal of structural demand rather than a seasonal fluctuation, suggesting that revenue growth will follow where new jobs are being created. Three specific stocks are positioned to capitalize on these macroeconomic trends: UnitedHealth Group (UNH), HCA Healthcare (HCA), and Encompass Health (EHC). UnitedHealth benefits from increased utilization across its insurance and Optum care delivery platforms. HCA, the largest hospital operator, sees direct revenue translation from rising inpatient and ambulatory volumes. Encompass Health targets the post-acute rehabilitation market, which is growing as patients require structured recovery before returning home. UnitedHealth Group reported Q1 2026 revenue of $111.7 billion, a 2% year-over-year increase, with its medical benefit ratio improving to 83.9%. Management raised full-year 2026 adjusted EPS guidance to above $18.25 per share. HCA Healthcare reported Q1 2026 revenue of $19.1 billion (up 4.3%) and operating cash flow that jumped 22% to $2 billion, while deploying $1.1 billion in capital expenditures. Encompass Health delivered its best earnings performance in recent history with Q1 2026 revenue growing 9% to $1.59 billion and adjusted EPS surging 16.8%. The company raised full-year 2026 revenue guidance to between $6.375 billion and $6.47 billion, citing an aging population and a structural shift toward higher-quality rehabilitation settings. Management is actively expanding capacity with seven new hospitals opening in 2026.